Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2005
09/27/2005US6949565 Protein kinase inhibitors
09/27/2005US6949563 (2-carboxamido)(3-amino)thiophene compounds
09/27/2005US6949562 Heterocyclic compounds as ligands of the GABAA receptor
09/27/2005US6949561 polycyclic compound comprises sulphamate group attached to one of the ring components, wherein ring is naphtho(2,1-f)quinoline
09/27/2005US6949558 Sequential administration of taxane and CDK1 antagonist for treatment of cancer, for inhibiting growth of tumors, and for inducing cellular apoptosis
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/27/2005US6949555 Use of organic compounds
09/27/2005US6949554 Calcium channel blockers comprising two benzhydril moieties
09/27/2005US6949553 Aliphatic compounds, their synthesis method, and utilization of the same
09/27/2005US6949552 Remedial agent for anxiety neurosis or depression and piperazine derivative
09/27/2005US6949551 Dihalopropene compounds, processes for their preparation, compositions comprising them and their use as pesticides
09/27/2005US6949548 administering a synergistic combination of levosimendan or a pharmaceutically acceptable salt thereof and a beta-adrenergic receptor antagonist to a patient in need of such treatment
09/27/2005US6949547 Antidiabetic agents; central nervous system disorders; cardiovascular disorders; hypotensive agents; anticancer agents
09/27/2005US6949546 N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
09/27/2005US6949545 Tissue remodeling; antiinflammatory agents; autoimmune disease
09/27/2005US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases
09/27/2005US6949542 Dihydro-benzo[b][1,4]diazepin-2-one derivatives
09/27/2005US6949541 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
09/27/2005US6949540 Substituted pyrazoles
09/27/2005US6949539 Antiinflammatory agents; autoimmune disease; rheumatic disorders
09/27/2005US6949538 Compounds, compositions, and methods
09/27/2005US6949537 LY294002 and analogs thereof comprising a reversibly quaternized amine; use of the pro-compounds for treatment of a condition associated with PI-3 kinase activity, including inflammatory disease, age-related macular degeneration, hypertension
09/27/2005US6949536 Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
09/27/2005US6949535 for example, 2-(6-aminopurin-9-ylmethyl)-3-(2-chlorophenyl)-6,7-dimethoxy-3H-quinazolin-4-one
09/27/2005US6949533 use in treating asthma, allergy, arthritis and thrombosis
09/27/2005US6949532 Use of mometasone furoate for treating airway passage and lung diseases
09/27/2005US6949531 14 β, 16, 17-methylene steroids as novel androgens
09/27/2005US6949530 Hypotensive agents
09/27/2005US6949529 Compositions containing lysophosphotidic acids which inhibit apoptosis and uses thereof
09/27/2005US6949528 Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof
09/27/2005US6949527 Muscle relaxation
09/27/2005US6949526 Erectile dysfunction remedies containing prostaglandin derivatives as the active ingredient
09/27/2005US6949525 In particular the treatment of osteochondral lesions associated with osteoarthritis by means of intraarticular application of a mixture of hyaluronate and chondroitin sulfate
09/27/2005US6949522 treating or preventing HIV infection, HBV infection or abnormal cellular proliferation by administering said compounds or the related beta -D and beta -L-2'-halo-4'-thionucleosides
09/27/2005US6949521 Therapeutic azide compounds
09/27/2005US6949519 Macrolide solvates
09/27/2005US6949518 Methods for treating macular degeneration with topiramate
09/27/2005US6949517 Method of treating inflammatory, tissue repair and infectious conditions
09/27/2005US6949515 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases
09/27/2005US6949514 Administering to a subject in need of such treatment, an agent in an amount effective to inhibit proliferation
09/27/2005US6949512 administering to patient effective amount of lipopolysaccharide binding protein to elevate serum concentration of lipopolysaccharide binding protein in patient to sufficiently high level to suppress lipopolysaccharide induced release of cytokine
09/27/2005US6949510 Uses of diterpenoid triepoxides as an anti-proliferative agent
09/27/2005US6949506 Relaxin-like factor and methods and uses thereof
09/27/2005US6949504 Composition comprising at least one liquid fatty phase structured by at least one semi-crystalline polymer
09/27/2005US6949361 Polynucleotide
09/27/2005US6949356 Methods for improving secondary metabolite production in fungi
09/27/2005US6949353 capable of acting as an guanylyltransferase and methyltransferase consisting of a polypeptide from the N-terminus of flavivirus genus RNA-dependent RNA polymerase
09/27/2005US6949349 incubating a phagemid clone displaying the peptide, with the IGF in the presence of the IGFBP at high and low concentrations of the phagemid clone, measuring the degree to which binding of the phagemid clone to the IGFBP is inhibited by IGF
09/27/2005US6949332 Silver halide emulsion and method of preparing the same
09/27/2005US6949263 Method for preparing nicotianamine or nicotianamine-containing product
09/27/2005US6949262 without petroleum products; aloe, dimethicone, allantoin, and water in a carrier base such as an oil, a cream, or a gel
09/27/2005US6949261 An isolate from the leaves of Gymnema sylvestre obtained by extracting Gymnema sylvestre leaves with aqueous ethanol, removing acid-insoluble salt from the extract, concentrating desalted extract, isolating an insulinotropically active principle
09/27/2005US6949260 Administering Boswellia gum extract comprising at least 10% by weight of boswellic acids, and turmeric gum extract comprising at least about 30% by weight of curcuminoids.
09/27/2005US6949259 Solid preparations for oral use
09/27/2005US6949257 Substance P antagonist; antidepressants; central nervous system disorders; respiratory system disorders
09/27/2005US6949255 Especially HIV; applying a polyquaternium, glycerin, or a preservative system such as methylparaben or proplyparaben.
09/27/2005US6949249 Mixture contains flow control agent and thickener
09/27/2005US6949244 produced by hybridoma cell line ATCC No. HB 12020; elicits an immune response against (human milk fat globule) HMFG in non-human primates
09/27/2005US6949242 Retroviral vector for the transfer and expression of genes for therapeutic purposes in eukaryotic cells
09/27/2005US6949240 Strip impregnated with peroxy compound
09/27/2005US6949218 Use of low molecular weight amino alcohols in ophthalmic compositions
09/27/2005US6949087 Apparatus with weeping tip and method of use
09/27/2005CA2414271C Sustained-release preparations of quinolone antibiotics and method for preparation thereof
09/27/2005CA2356747C Triphasic oral contraceptive
09/27/2005CA2299355C Aryloxyarylsulfonylamino hydroxamic acid derivatives
09/27/2005CA2255539C Therapeutic uses of bpi protein products in humans with hemorrhage due to trauma
09/27/2005CA2241825C New monofunctionalized edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
09/27/2005CA2193337C 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol compounds as pharmaceutical active ingredients
09/27/2005CA2173876C Alkoxy alkyl carbamates from imidazo(1,2-a)pyridines
09/27/2005CA2122346C Bistriazenes as chemotherapeutic agents
09/27/2005CA2121997C 3-deoxy oligosaccharides, processes for preparing them and pharmaceutical compositions containing them
09/27/2005CA2120942C Nitric esters of derivatives of the 2-(2,6-di-halo-phenylamino)phenyl-acetic acid and process for their preparation
09/27/2005CA2093306C (1-h-indol-1-yl)-2-(amino)acetamides and related (1h-indol-1-yl)-(aminoalkyl)amides, intermediates and a process for their preparation and their use as medicaments
09/27/2005CA2079814C Cationic lipids for intracellular delivery of biologically active molecules
09/27/2005CA2068970C Agent for transdermal administration containing ergoline derivatives
09/23/2005CA2502169A1 Products and methods for treating vaginal infections
09/22/2005WO2005087923A1 A small synthetic rna, a method of preparing the same and uses thereof
09/22/2005WO2005087787A1 2-fluoro-6-o-substituted ketolide derivative
09/22/2005WO2005087786A1 Derivatives of genkwanin and sakuranetin, cosmetic and therapeutic use thereof and preparation method of same
09/22/2005WO2005087778A1 Tricyclic furopyridine derivatives useful in the treatment of hyper-proliferative disorders
09/22/2005WO2005087775A1 Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient
09/22/2005WO2005087768A1 Hiv integrase inhibitors
09/22/2005WO2005087767A1 Hiv integrase inhibitors
09/22/2005WO2005087763A1 Diphenylmethyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087762A1 Novel indole derivative for alkylating specific base sequence of dna and alkylating agent and drug each comprising the same
09/22/2005WO2005087761A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
09/22/2005WO2005087754A1 Substituted morpholine and thiomorpholine derivatives
09/22/2005WO2005087752A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005087751A2 Substituted hydroxyethylamine aspartyl protease inhibitors
09/22/2005WO2005087749A1 2-aminoquinazoline derivative
09/22/2005WO2005087747A1 Ion channel modulators
09/22/2005WO2005087743A1 Tetrahydroisoquinoline-and tetrahydrobenzazepine derivatives as igf-1r inhibitors
09/22/2005WO2005087742A1 Metabolic kinase modulators and methods of use as pesticides
09/22/2005WO2005087739A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087738A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087737A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087736A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087735A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087734A1 Biphenyl compounds useful as muscarinic receptor antagonists
09/22/2005WO2005087733A1 Biphenyl compounds useful as muscarinic receptor antagonists
1 ... 4529 4530 4531 4532 4533 4534 4535 4536 4537 4538 4539 4540 4541 4542 4543 4544 4545 4546 4547 4548 4549 ... 7860